Table 1.
SL (μm) | Passive tension (mN mm−2) | Maximal tension (mN mm−2) | PCa50 | nH | ||
---|---|---|---|---|---|---|
Fig. 2A (control) | BLV(n = 8) | 1.9 | ˜0 | 21.36 ± 2.18 | 5.65 ± 0.01 | 3.66 ± 0.34 |
2.4 | 6.71 ± 0.42* | 39.57 ± 3.10* | 5.88 ± 0.03* | 3.77 ± 0.13 | ||
BLA (n = 8) | 1.9 | ˜0 | 17.61 ± 1.17 | 5.61 ± 0.02 | 3.50 ± 0.36 | |
2.4 | 3.50 ± 0.24 | 27.08 ± 2.69 | 5.74 ± 0.02 | 3.36 ± 0.26 | ||
Fig. 2B (high PT) | BLV(n = 6) | 1.9 | ˜0 | 24.75 ± 2.05 | 5.65 ± 0.03 | 4.98 ± 0.53 |
2.4 | 9.22 ± 0.62† | 48.94 ± 3.20† | 5.98 ± 0.04† | 4.13 ± 0.38 | ||
Fig. 2C (high PT) | BLA (n = 5) | 1.9 | ˜0 | 21.05 ± 1.24 | 5.62 ± 0.01 | 4.30 ± 0.30 |
2.4 | 6.80 ± 0.41† | 35.84 ± 2.45† | 5.84 ± 0.02† | 3.49 ± 0.12 |
Maximal tension was obtained by activating muscle at pCa 4.5 prior to construction of the pCa–tension relationship at each SL (passive tension, just prior to pCa 4.5 activation). High PT, high passive tension.
P < 0.05 compared with corresponding values for BLA.
P < 0.05 compared with corresponding values obtained in experiments under the control condition (Fig. 2A).